Pediatric brain tumor consortium multisite assessment of apparent diffusion coefficient z-axis variation assessed with an ice-water phantom.

RATIONALE AND OBJECTIVES Magnetic resonance diffusion imaging can characterize physiologic characteristics of pediatric brain tumors used to assess therapy response. The purpose of this study was to assess the variability of the apparent diffusion coefficient (ADC) along z-axis of scanners in the multicenter Pediatric Brain Tumor Consortium (PBTC). MATERIALS AND METHODS Ice-water diffusion phantoms for each PBTC site were distributed with a specific diffusion imaging protocol. The phantom was scanned four successive times to 1) confirm water in the tube reached thermal equilibrium and 2) allow for assessment of intra-examination ADC repeatability. ADC profiles across slice positions for each vendor and institution combination were characterized using linear regression modeling with a quadratic fit. RESULTS Eleven sites collected data with a high degree of compliance to the diffusion protocol for each scanner. The mean ADC value at slice position zero for vendor A was 1.123 × 10(-3) mm(2)/s, vendor B was 1.0964 × 10(-3) mm(2)/s, and vendor C was 1.110 × 10(-3) mm(2)/s. The percentage coefficient of variation across all sites was 0.309% (standard deviation = 0.322). The ADC values conformed well to a second-order polynomial along the z-axis, (ie, following a linear model pattern with quadratic fit) for vendor-institution combinations and across vendor-institution combinations as shown in the longitudinal model. CONCLUSIONS Assessment of the variability of diffusion metrics is essential for establishing the validity of using these quantitative metrics in multicenter trials. The low variability in ADC values across vendors and institutions and validates the use of ADC as a quantitative tumor marker in pediatric multicenter trials.

[1]  Thomas L Chenevert,et al.  Diffusion imaging for therapy response assessment of brain tumor. , 2009, Neuroimaging clinics of North America.

[2]  S. Treves,et al.  The Neuroimaging Center of the Pediatric Brain Tumor Consortium-collaborative neuroimaging in pediatric brain tumor research: a work in progress. , 2007, AJNR. American journal of neuroradiology.

[3]  Raúl San José Estépar,et al.  Complementary aspects of diffusion imaging and fMRI; I: structure and function. , 2006, Magnetic resonance imaging.

[4]  C. Meyer,et al.  Diffusion coefficient measurement using a temperature‐controlled fluid for quality control in multicenter studies , 2011, Journal of magnetic resonance imaging : JMRI.

[5]  L. Ries,et al.  Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. , 1999 .

[6]  C. Meyer,et al.  Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. , 2002, Molecular imaging.

[7]  Kevin Dewey,et al.  Establishment and results of a magnetic resonance quality assurance program for the pediatric brain tumor consortium. , 2008, Academic radiology.

[8]  P. Choyke,et al.  Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.

[9]  R C McKinstry,et al.  Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. , 2001, AJR. American journal of roentgenology.

[10]  Timothy D Johnson,et al.  Multi‐system repeatability and reproducibility of apparent diffusion coefficient measurement using an ice‐water phantom , 2013, Journal of magnetic resonance imaging : JMRI.

[11]  Thomas L Chenevert,et al.  Analysis and correction of gradient nonlinearity bias in apparent diffusion coefficient measurements , 2014, Magnetic resonance in medicine.